Join the 'Kybella' group to help and get support from people like you.
Posted 30 Apr 2015 by Drugs.com
April 29, 2015 – The U.S. Food and Drug Administration today approved Kybella (deoxycholic acid), a treatment for adults with moderate-to-severe fat below the chin, known as submental fat. Using Kybella for the treatment of fat outside of the submental area is not approved and is not recommended. Kybella is identical to the deoxycholic acid that is produced in the body. Deoxycholic acid produced in the body helps the body absorb fats. Kybella is a cytolytic drug, which when injected into tissue physically destroys the cell membrane. When properly injected into submental fat, the drug destroys fat cells; however, it can also destroy other types of cells, such as skin cells, if it is inadvertently injected into the skin. “Treatment with Kybella should only be provided by a licensed health care professional, and patients should fully understand the risks associated with use of the drug b ... Read more
Posted 29 Apr 2015 by Drugs.com
WEDNESDAY, April 29, 2015 – Kybella (deoxycholic acid) has been approved by the U.S. Food and Drug Administration to treat excess fat below the chin, a condition best known as "double chin." Kybella is identical to the body chemical deoxycholic acid, which helps absorb and destroy fats, the FDA said Wednesday in a news release. But the agency warned the drug is not meant to target fats elsewhere in the body, and could destroy healthy cells in the skin and elsewhere if injected improperly. The drug is approved to be injected into fat tissue in the "submental" area, located just below the chin. Kybella's safety and effectiveness were evaluated in clinical studies involving more than 1,000 people with moderate-to-severe submental fat. The drug can cause serious side effects, the agency warned, including nerve injury in the jaw, uneven smile, facial muscle weakness and trouble swallowing. ... Read more